Physician profile
Christopher M Fleming
NPI 1871596171
$1,184.96
in general payments reported to CMS, 2019-2025
25 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $128 · 2023: $228 · 2024: $250 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $827.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $328.31 | 2023-2025 | Veozah |
| Abbvie INC. | $326.42 | 2019-2023 | |
| Exeltis, USA INC. | $56.09 | 2019-2025 | Slynd |
| Novo Nordisk INC | $42.65 | 2025 | Rybelsus, Ozempic |
| Exact Sciences Corporation | $40.77 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $39.53 | 2023-2025 | |
| Organon LLC | $33.17 | 2024-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $30.13 | 2023-2024 | Myfembree |
| Aspira Women'S Health INC | $26.95 | 2024 | Ova1 |
| Sage Therapeutics, LLC | $23.78 | 2024 | |
| Amag Pharmaceuticals, INC. | $23.78 | 2019-2020 | |
| Gynesonics, INC. | $20.80 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $20.04 | 2025 | Aptima, Thinprep 2000 Processor |
| Medtronic, INC. | $18.02 | 2025 | Ligasure |
| Sanofi Pasteur INC. | $17.81 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $16.93 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.91 | 2019 | |
| Sanara Medtech INC. | $16.86 | 2024 | Celleraterx |
| Smith+Nephew, INC. | $14.47 | 2025 | Pico 14 |
| Caldera Medical, INC | $14.34 | 2023 | Desara |
| Minerva Surgical, INC | $13.72 | 2023 | |
| Pfizer INC. | $12.86 | 2023 | |
| Therapeuticsmd, INC. | $11.37 | 2019 | |
| Conmed Corporation | $10.97 | 2019 | |
| Meditrina | $8.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Fleming listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.